Citation tools
"Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.." The Journal of Rheumatology
34.3
(2007):
634-640.
Web. 02 July. 2022.